CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $156,000 | -72.8% | 789,260 | -37.9% | 0.02% | -43.8% |
Q3 2018 | $573,000 | +78.0% | 1,270,500 | +98.6% | 0.03% | +100.0% |
Q2 2018 | $322,000 | -87.7% | 639,800 | +514.8% | 0.02% | -84.2% |
Q2 2015 | $2,625,000 | +70.5% | 104,074 | +88.4% | 0.10% | +65.6% |
Q1 2015 | $1,540,000 | +623.0% | 55,255 | +358.9% | 0.06% | +306.7% |
Q1 2014 | $213,000 | -74.1% | 12,041 | -64.6% | 0.02% | -76.9% |
Q4 2013 | $823,000 | -57.4% | 34,004 | -37.6% | 0.06% | -57.5% |
Q3 2013 | $1,931,000 | +127.7% | 54,495 | +0.3% | 0.15% | +51.5% |
Q2 2013 | $848,000 | – | 54,319 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
Bellevue Group AG | 160,000 | $646,000 | 0.12% |
PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |